MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, People's Republic of China.
Dr Li Dak Sum and Yip Yio Chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Biomed Mater. 2021 Aug 27;16(5). doi: 10.1088/1748-605X/ac1d3c.
Traumatic spinal cord injury (SCI) usually results in restricted behaviour recovery and even life-changing paralysis, accompanied with numerous complications. Pathologically, the initial injuries trigger a series of secondary injuries, leading to an expansion of lesion site, a mass of neuron loss, and eventual failure of endogenous axon regeneration. As the advances rapidly spring up in regenerative medicine and tissue engineering biomaterials, regulation of these secondary injuries becomes possible, shedding a light on normal functional restoration. The successful tissue regeneration lies in proper regulation of the inflammatory microenvironment, including the inflammatory immune cells and inflammatory factors that lead to oxidative stress, inhibitory glial scar and neuroexcitatory toxicity. Specifically, the approaches based on microenvironment-regulating biomaterials have shown great promise in the repair and regeneration of SCI. In this review, the pathological inflammatory microenvironments of SCI are discussed, followed by the introduction of microenvironment-regulating biomaterials in terms of their impressive therapeutic effect in attenuation of secondary inflammation and promotion of axon regrowth. With the emphasis on regulating secondary events, the biomaterials for SCI treatment will become promising for clinical applications.
创伤性脊髓损伤 (SCI) 通常导致受限的行为恢复,甚至是改变生活的瘫痪,并伴有许多并发症。从病理学上讲,最初的损伤引发了一系列继发性损伤,导致病变部位扩大、大量神经元丧失,最终导致内源性轴突再生失败。随着再生医学和组织工程生物材料的迅速发展,对这些继发性损伤的调控成为可能,为正常功能的恢复带来了希望。组织的成功再生取决于炎症微环境的适当调节,包括导致氧化应激、抑制性神经胶质瘢痕和神经兴奋毒性的炎症免疫细胞和炎症因子。具体来说,基于微环境调节生物材料的方法在 SCI 的修复和再生方面显示出了巨大的前景。在这篇综述中,讨论了 SCI 的病理性炎症微环境,然后介绍了微环境调节生物材料,这些生物材料在减轻继发性炎症和促进轴突再生方面具有显著的治疗效果。通过强调对继发性事件的调节,用于 SCI 治疗的生物材料将有望在临床上得到应用。